Stay updated on FRα Clinical Trial: Mirvetuximab vs. Chemo
Sign up to get notified when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.

Latest updates to the FRα Clinical Trial: Mirvetuximab vs. Chemo page
- CheckyesterdayChange DetectedLocations section replaced with a comprehensive new list of study sites across the US, Canada, and Europe. Old per-state location groupings were removed, and the page revision was updated to v3.3.3.SummaryDifference2%

- Check8 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedThe Publications section text now states that publications are automatically filled from PubMed, and the revision labels show v3.3.2 (replacing v3.2.0). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check37 days agoChange DetectedNotice about government funding status on the NIH Clinical Center page is removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check51 days agoChange DetectedThe Locations section was updated to reflect changes in participating study sites. These updates affect where patients can enroll and where results may apply.SummaryDifference0.2%

- Check80 days agoChange DetectedMajor change: the page adds a government operating-status notice and updates the version to v3.2.0, while removing the previous v3.1.0 reference.SummaryDifference2%

- Check87 days agoChange DetectedIntroduces version v3.1.0 and removes the term 'Ovarian cancer', indicating a page update with topic scope refinement.SummaryDifference0.1%

Stay in the know with updates to FRα Clinical Trial: Mirvetuximab vs. Chemo
Enter your email address, and we'll notify you when there's something new on the FRα Clinical Trial: Mirvetuximab vs. Chemo page.